A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors.

被引：0
|
作者：
Dela Cruz, Filemon S.
Fox, Elizabeth
Muscal, Jodi Ann
Kirov, Ivan
Geller, James I.
DuBois, Steven G.
Kim, AeRang
Croop, James
Laetsch, Theodore Willis
Minard, Charles G.
Liu, Xiaowei
Weigel, Brenda
Okpara, Chinyere E.
Huang, Jie
Dutta, Lea
Aluri, Jagadeesh
Bender, Julia Lynne Glade
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] CHOC Childrens Hosp, Orange, CA USA
[5] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[6] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[7] Harvard Med Sch, Boston, MA 02115 USA
[8] Childrens Natl Hosp, Washington, DC USA
[9] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[10] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[11] Childrens Hlth, Dallas, TX USA
[12] Childrens Oncol Grp, Monrovia, CA USA
[13] Univ Minnesota, Minneapolis, MN USA
[14] Eisai Ltd, Hatfield, Herts, England
[15] Eisai Inc, Woodcliff Lake, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10527
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Phase 1/2 Study of Lenvatinib (LEN) Plus Everolimus (EVE) in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors
    Dela Cruz, F.
    Fox, E.
    Muscal, J.
    Kirov, I.
    Geller, J.
    Dubois, S.
    Kim, A.
    Croop, J.
    Laetsch, T.
    Minard, C.
    Liu, X.
    Weigel, B.
    Okpara, C.
    Huang, J.
    Dutta, L.
    Aluri, J.
    Bender, J. Glade
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S20 - S21
  • [2] A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.
    Wood, Paul James
    Strong, Robyn
    McArthur, Grant A.
    Michael, Michael
    Algar, Elizabeth
    Muscat, Andrea
    Rigby, Lin
    Ashley, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] A PHASE I STUDY OF VINBLASTINE AND SIROLIMUS IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING CNS TUMORS
    Marzouki, Monia
    Bartels, Ute
    Gammon, Janet
    Bergendahl, Genevieve
    Yankanah, Rosanna
    Wu, Bing
    Samson, Yvan
    Sholler, Giselle
    Irwin, Meredith S.
    Baruchel, Sylvain
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1091 - 1091
  • [4] A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors
    Paul J. Wood
    Robyn Strong
    Grant A. McArthur
    Michael Michael
    Elizabeth Algar
    Andrea Muscat
    Lin Rigby
    Melissa Ferguson
    David M. Ashley
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 493 - 503
  • [5] A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors
    Wood, Paul J.
    Strong, Robyn
    McArthur, Grant A.
    Michael, Michael
    Algar, Elizabeth
    Muscat, Andrea
    Rigby, Lin
    Ferguson, Melissa
    Ashley, David M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (03) : 493 - 503
  • [6] RESULTS OF THE PHASE 2 COHORT OF LENVATINIB (LEN) PLUS EVEROLIMUS (EVE) IN RECURRENT/REFRACTORY CHILDHOOD SOLID TUMORS, PERFORMED IN COLLABORATION WITH THE CHILDREN'S ONCOLOGY GROUP
    Dela Cruz, Filemon
    Fox, Elizabeth
    Dubois, Steven
    Friedman, Gregory
    Croop, James
    Kim, Aerang
    Morgenstern, Daniel
    Balis, Frank
    Macy, Margaret
    Pressey, Joseph
    Watt, Tanya
    Krystal, Julie
    Vo, Kieuhoa
    Mody, Rajen
    Laetsch, Theodore
    Weigel, Brenda
    O'Hara, Karen
    Okpara, Chinyere
    He, Cixin
    Bender, Julia
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [7] Phase I study of everolimus in pediatric patients with refractory solid tumors
    Fouladi, Maryam
    Laningham, Fred
    Wu, Jianrong
    O'Shaughnessy, Melinda A.
    Molina, Kristen
    Broniscer, Alberto
    Spunt, Sheri L.
    Luckett, Inga
    Stewart, Clinton F.
    Houghton, Peter J.
    Gilbertson, Richard J.
    Furman, Wayne L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4806 - 4812
  • [8] A phase I study of sirolimus in combination with metronomic therapy in children with recurrent and refractory solid/CNS tumors.
    Qayed, Muna
    Cash, Thomas
    Tighiouart, Mourad
    MacDonald, Tobey
    Goldsmith, Kelly C.
    Kean, Leslie S.
    Church, Patty
    Katzenstein, Howard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumors.
    Casanova, Michela
    Kramm, Christof
    Reinhardt, Dirk
    Locatelli, Franco
    D'Adamo, David R.
    Scott, Rachael
    Jia, Yan
    Aluri, Jagadeesh
    Favre, Claudio
    Bautista, Francisco
    Alvaro, Raquel Hladun
    Urgelles, Ana Sastre
    Kontny, Udo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Updated entrectinib data in children and adolescents with recurrent or refractory solid tumors, including primary CNS tumors.
    Desai, Ami Vijay
    Robinson, Giles W.
    Basu, Ellen M.
    Foster, Jennifer
    Gauvain, Karen
    Sabnis, Amit
    Shusterman, Suzanne
    Macy, Margaret E.
    Maese, Luke
    Yoon, Janet
    Cash, Thomas
    Abdelbaki, Mohamed
    Nazemi, Kellie
    Weiss, Brian D.
    Chohan, Saibah
    Cardenas, Alison
    Hutchinson, Katherine
    Bergthold, Guillaume
    Gajjar, Amar J.
    Fox, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345